SKU: DASLEMIA-100MG-30TAB
Daslemia 100mg Tablet contains Dasatinib 100mg, a prescription tyrosine kinase inhibitor used under specialist supervision for certain blood cancers, including chronic myeloid leukemia (CML). It works by blocking abnormal protein signals involved in the growth of leukemia cells.
Daslemia 100mg Tablet contains Dasatinib 100mg, a prescription tyrosine kinase inhibitor used under the supervision of a qualified oncologist for certain types of blood cancer.
Daslemia 100mg Tablet is prescribed for certain blood cancers where Dasatinib treatment is considered appropriate by a specialist.
Daslemia contains Dasatinib, which belongs to the tyrosine kinase inhibitor class. It works by blocking abnormal tyrosine kinase proteins involved in the growth and survival of certain leukemia cells.
Take Daslemia 100mg Tablet exactly as prescribed by your oncologist or qualified healthcare professional. It may generally be taken with or without food. Swallow the tablet whole with water and do not crush, chew, split, or break it unless specifically instructed by your doctor.
The appropriate dose depends on the type and phase of leukemia, age, medical condition, previous treatment, response to therapy, and other medicines being used. For some adults with chronic-phase CML, Dasatinib 100mg once daily is an established treatment regimen. The treating oncologist should determine the appropriate dose for each patient.
Dasatinib provides targeted inhibition of abnormal tyrosine kinase signaling involved in certain leukemia cells. This can help control the growth and multiplication of abnormal blood cells when the medicine is medically appropriate.
Possible side effects may include nausea, vomiting, diarrhea, abdominal discomfort, headache, fatigue, rash, cough, fever, fluid retention, and changes in blood cell counts.
Dasatinib may affect blood cell counts and can increase the risk of infection, anemia, bruising, or bleeding. It may also cause fluid retention, including fluid around the lungs or heart.
Seek urgent medical attention for severe difficulty breathing, chest pain, significant bleeding, fainting, severe swelling, or a fast or irregular heartbeat.
Dasatinib can interact with medicines that affect the CYP3A4 enzyme system. Tell your doctor about all prescription medicines, over-the-counter medicines, vitamins, supplements, and herbal products you use.
Grapefruit and grapefruit juice should generally be avoided during Dasatinib treatment because they may increase the amount of Dasatinib in the body.
Dasatinib may cause harm to an unborn baby. Patients who are pregnant or planning pregnancy should discuss the risks and appropriate precautions with their healthcare professional.
Discuss breastfeeding with your treating doctor before using Daslemia. Follow your healthcare professional's advice regarding breastfeeding during treatment.
If you miss a dose, follow the instructions provided by your oncologist or pharmacist. Do not take a double dose unless specifically instructed by your healthcare professional.
Store Daslemia 100mg Tablet according to the product packaging instructions. Keep it away from excessive heat and moisture and out of reach of children.
Daslemia 100mg Tablet should be used only under qualified medical supervision. Regular blood tests and follow-up appointments may be required during treatment. Do not change the dose or stop treatment without consulting your doctor.
For additional information about Dasatinib, visit the MedlinePlus Dasatinib Information.
For official U.S. regulatory drug information, visit the FDA Drugs@FDA Database.
For general healthcare information, visit the NHS Health Information website.
Explore the Immunosuppressants Category for related prescription medicine information.
Visit the Antibiotics Category to explore other prescription medicines.
Daslemia 100mg Tablet is a prescription medicine containing Dasatinib 100mg. It is a tyrosine kinase inhibitor used under specialist supervision for certain types of leukemia.
It is used for certain types of chronic myeloid leukemia and other appropriate Philadelphia chromosome-positive leukemia conditions.
The active ingredient is Dasatinib 100mg.
Dasatinib may generally be taken with or without food. Follow your doctor's instructions.
Grapefruit and grapefruit juice should generally be avoided because they may increase Dasatinib exposure.
Yes. Daslemia 100mg is a prescription anticancer medicine and should be used under appropriate medical supervision.
Daslemia 100mg Tablet is a prescription anticancer medicine. This information is provided for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always use Daslemia according to the prescription and monitoring instructions provided by your qualified healthcare professional.
| Brand | Daslemia |
| Manufacturer | Intas Pharmaceuticals Ltd |
| Composition | Dasatinib 100mg |
| Package | Bottle of 30 Tablets |
| Ship time | 3-7 Days |
Free Shipping
For all oders over $99
Secure Payment
100% secure payment
24/7 Support
Online top support